Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry A Schechter

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 25, 2008
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitisBarry A Schechter
Clinical Ophthalmology (Auckland, N.Z.)|September 20, 2019
Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studiesBarry A Schechter
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 26, 2006
Ketorolac during the induction phase of cyclosporin-A therapyBarry A Schechter
Advances in Therapy|September 17, 2010
Efficacy and safety of bromfenac for the treatment of corneal ulcer painBarry A Schechter, William Trattler
Journal of Cataract and Refractive Surgery|March 23, 2011
Endothelial survival after Descemet-stripping automated endothelial keratoplasty in eyes with retained anterior chamber intraocular lenses: two-year follow-upSalomon Esquenazi, Barry A Schechter, Karina Esquenazi
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 20, 2014
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial keratitis: a retrospective safety surveillance studyBarry A Schechter, Jai G Parekh, William Trattler
Clinical Ophthalmology (Auckland, N.Z.)|August 18, 2020
Pterygium Surgery Utilizing Limbal Conjunctival Autograft and Subconjunctival Amniotic Membrane Graft in High-Risk PopulationsAlexander Shusko, Barry A Schechter, John A Hovanesian
Advances in Therapy|June 25, 2009
Efficacy of topical cyclosporine for the treatment of ocular rosaceaBarry A Schechter, Randy S Katz, Lee S Friedman
Ophthalmology|June 27, 2006
Ocular infections caused by Providencia rettgeriAaleya F Koreishi, Barry A Schechter, Carol L Karp
Ophthalmology|January 12, 2008
Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2bBarry A Schechter, Aaleya F Koreishi, Carol L Karp, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|April 25, 2008
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitisBarry A Schechter
Clinical Ophthalmology (Auckland, N.Z.)|September 20, 2019
Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studiesBarry A Schechter
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 26, 2006
Ketorolac during the induction phase of cyclosporin-A therapyBarry A Schechter
Advances in Therapy|September 17, 2010
Efficacy and safety of bromfenac for the treatment of corneal ulcer painBarry A Schechter, William Trattler
Journal of Cataract and Refractive Surgery|March 23, 2011
Endothelial survival after Descemet-stripping automated endothelial keratoplasty in eyes with retained anterior chamber intraocular lenses: two-year follow-upSalomon Esquenazi, Barry A Schechter, Karina Esquenazi
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 20, 2014
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial keratitis: a retrospective safety surveillance studyBarry A Schechter, Jai G Parekh, William Trattler
Clinical Ophthalmology (Auckland, N.Z.)|August 18, 2020
Pterygium Surgery Utilizing Limbal Conjunctival Autograft and Subconjunctival Amniotic Membrane Graft in High-Risk PopulationsAlexander Shusko, Barry A Schechter, John A Hovanesian
Advances in Therapy|June 25, 2009
Efficacy of topical cyclosporine for the treatment of ocular rosaceaBarry A Schechter, Randy S Katz, Lee S Friedman
Ophthalmology|June 27, 2006
Ocular infections caused by Providencia rettgeriAaleya F Koreishi, Barry A Schechter, Carol L Karp
Ophthalmology|January 12, 2008
Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2bBarry A Schechter, Aaleya F Koreishi, Carol L Karp, et al.
Pageof 2